AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 4,705.00
-210.00 (-4.27%)
Jul 24, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 132.18 billion as of July 24, 2026. Its market cap has decreased by -47.24% in one year.
Market Cap
132.18B
Enterprise Value
128.00B
Revenue
4.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,705.00
ChartMarket Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 132.18B, a decrease of -68.77%. That is a compound annual growth rate of -15.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 132.18B | -47.41% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daewon Pharmaceutical | 162.25B |
| BNC KOREA | 158.68B |
| Daihan Pharmaceutical | 152.29B |
| Hana Pharm | 148.58B |
| Ilyang Pharmaceutical Co.,Ltd | 145.73B |
| Jeil Pharmaceutical Co.,Ltd | 142.66B |
| Ilsung Is | 141.12B |
| Dongwha Pharm.Co.,Ltd | 136.10B |